Mednax closed the issuance of $400 million in unsecured 5.375% Senior Notes due 2030 in a private offering. Mednax concurrently closed on a new $450 million unsecured revolving credit facility and a new $250 million Term A Loan, replacing its previous $600 million unsecured revolving credit facility.
Together with cash on hand, Mednax used the proceeds of these transactions to redeem its $1 billion in 6.25% Senior Notes due 2027. Following these transactions, Mednax’s outstanding debt was approximately $750 million.
Mednax is a national medical group comprised of physicians practicing under the Pediatrix® brand. Read more.
